So far, 18F-FDG is the most widely used tracer as described above; however, there is a strong trend towards radioligands, which target more specific tumor features rather than only glucose metabolism, e.g. PSMA-targeted ligands for prostate cancer imaging or SSR-directed ligands for meningioma imaging. The gene discussed is FOLH1; the disease is prostate carcinoma.